Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial.
Am J Hematol
; 98(4): E84-E87, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-36655608
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
2_ODS3
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Am J Hematol
Year:
2023
Document type:
Article